Gregory Riely, MD, PhD
Memorial Sloan Kettering Cancer · Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gregory Riely, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06582771 · A Study of Sotorasib in People With Non-Small Cell Lung CancerMemorial Sloan Kettering Cancer Center · recruiting · Non Small Lung Cancer · principal investigator
- Ph1/Ph2NCT06007937 · A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Non Small Cell Lung Cancer, Metastatic, Recurrent · principal investigator
- Ph1NCT03681483 · RO5126766 for Patients With Advanced KRAS-Mutant Lung CancerMemorial Sloan Kettering Cancer Center · completed · Advanced Non-small Cell Lung Cancer · principal investigator
- Ph2NCT01833143 · Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12DMemorial Sloan Kettering Cancer Center · completed · Non-Small Cell Lung Cancer · principal investigator
- N/ANCT01300429 · Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene LocusMemorial Sloan Kettering Cancer Center · completed · Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.